BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 03/31/2015

Position Statistics

Total Positions 91
New Positions 22
Increased Positions 38
Decreased Positions 33
Positions with Activity 71
Sold Out Positions 12
Total Mkt Value (in $ millions) 1,531

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.07%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 0.66%
Healthcare 83.71%
Services
Technology 1.45%
Transportation
Utilities

22 New Positions as of 03/31/2015

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
ORASURE TECHNOLOGIES INC COM 262 262 New 50,000
FATE THERAPEUTICS INC COM 505 505 New 70,428
MELA SCIENCES INC COM NEW 682 682 New 587,915
TANDEM DIABETES CARE INC COM 1,194 1,194 New 101,957
XOMA CORP DEL COM 1,314 1,314 New 1,500,000
GENOMIC HEALTH INC COM 2,017 2,017 New 75,000
UNILIFE CORP NEW COM 2,105 2,105 New 1,150,000
BOVIE MEDICAL CORP COM 2,123 2,123 New 1,011,000
TEARLAB CORP COM 2,177 2,177 New 914,499
TORNIER N V SHS 2,502 2,502 New 100,000
CAPRICOR THERAPEUTICS INC COM 3,134 3,134 New 705,882
ZOSANO PHARMA CORP COM 3,856 3,856 New 485,000
BIOLINERX LTD SPONSORED ADR 5,177 5,177 New 3,100,000
EPIRUS BIOPHARMACEUTICALS INC COM 5,410 5,410 New 775,000
OHR PHARMACEUTICAL INC COM NEW 5,609 5,609 New 1,775,000
SPECTRUM PHARMACEUTICALS INC COM 5,632 5,632 New 800,000
VERASTEM INC COM 8,012 8,012 New 1,050,000
LION BIOTECHNOLOGIES INC COM 9,360 9,360 New 1,062,419
ALCOBRA LTD SHS 11,686 11,686 New 1,556,016
ADVAXIS INC COM NEW 14,161 14,161 New 805,994